Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia
Authors
Keywords
-
Journal
Current Opinion in Endocrinology Diabetes and Obesity
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-10-30
DOI
10.1097/med.0000000000000842
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial
- (2023) Kausik K Ray et al. Lancet Diabetes & Endocrinology
- Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia
- (2023) Hayato Tada et al. ATHEROSCLEROSIS
- Patient adherence to fully reimbursed proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9i) treatment
- (2023) Alissia Stummer et al. WIENER KLINISCHE WOCHENSCHRIFT
- Impact of Patient Visualization of Cardiovascular Images on Modification of Cardiovascular Risk Factors
- (2023) Kristyn Whitmore et al. JACC-Cardiovascular Imaging
- Strategies of improving adherence to lipid-lowering therapy in patients with atherosclerotic cardiovascular disease
- (2023) Dean G. Karalis CURRENT OPINION IN LIPIDOLOGY
- Advantages and Disadvantages of Inclisiran: A Small Interfering Ribonucleic Acid Molecule Targeting PCSK9—A Narrative Review
- (2022) Iveta Merćep et al. Cardiovascular Therapeutics
- Prevalence of statin intolerance: a meta-analysis
- (2022) Ibadete Bytyçi et al. EUROPEAN HEART JOURNAL
- Reduction of cardiovascular events with the use of lipid-lowering medication in patients with familial hypercholesterolemia or severe primary hypercholesterolemia: A systematic review
- (2022) Walter Masson et al. Journal of Clinical Lipidology
- Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolaemia: Practical advice for the community clinician
- (2022) Ari E Horton et al. JOURNAL OF PAEDIATRICS AND CHILD HEALTH
- Nonadherence to lipid‐lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease
- (2022) Nihar R. Desai et al. CLINICAL CARDIOLOGY
- World Heart Federation Cholesterol Roadmap 2022
- (2022) Kausik K. Ray et al. Global Heart
- Adherence to statin treatment in patients with familial hypercholesterolemia: A dynamic prediction model
- (2022) Arjen J. Cupido et al. Journal of Clinical Lipidology
- Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study
- (2022) Rodrigo Alonso et al. European Journal of Preventive Cardiology
- Understanding how educational interventions improve treatment adherence in patients with familial hypercholesterolaemia: a systematic review
- (2022) Hannah Massey et al. Journal of Community Genetics
- LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial
- (2021) Antonio J. Vallejo-Vaz et al. ATHEROSCLEROSIS
- Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
- (2021) Antonio J. Vallejo-Vaz et al. LANCET
- Medication adherence in cardiovascular medicine
- (2021) Steven T Simon et al. BMJ-British Medical Journal
- Treatment Inertia in Patients With Familial Hypercholesterolemia
- (2021) Anatoly Langer et al. Journal of the American Heart Association
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
- (2020) Jan Borén et al. EUROPEAN HEART JOURNAL
- Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care
- (2020) Gerald F. Watts et al. Nature Reviews Cardiology
- Reasons for Nonadherence to Statins – A Systematic Review of Reviews
- (2020) Marianne Vie Ingersgaard et al. Patient Preference and Adherence
- Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National Registry
- (2020) Jing Pang et al. Heart Lung and Circulation
- Barriers, facilitators, and solutions to familial hypercholesterolemia treatment
- (2020) Laney K. Jones et al. PLoS One
- Association between Lipid Testing and Statin Adherence in the Veterans Affairs Health System
- (2019) Xiaoming Jia et al. AMERICAN JOURNAL OF MEDICINE
- Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system
- (2019) Rachelle Louise Cutler et al. Patient Preference and Adherence
- The patient journey with proprotein convertase subtilisin/kexin type 9 inhibitors in community practice
- (2019) Corey K. Bradley et al. Journal of Clinical Lipidology
- Enablers and barriers to treatment adherence in heterozygous familial hypercholesterolaemia: a qualitative evidence synthesis
- (2019) Fiona J Kinnear et al. BMJ Open
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia
- (2019) Ilse K. Luirink et al. NEW ENGLAND JOURNAL OF MEDICINE
- PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study
- (2019) Carlo Piccinni et al. CLINICAL DRUG INVESTIGATION
- Treatment goal attainment in children with familial hypercholesterolemia: A cohort study of 302 children in Norway
- (2018) Martin P. Bogsrud et al. Journal of Clinical Lipidology
- Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia
- (2018) Martin S. Hagger et al. ATHEROSCLEROSIS
- Adverse Events Associated With PCSK9 Inhibitors: A Real-World Experience
- (2018) Muhammed T. Gürgöze et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial
- (2018) Ulf Näslund et al. LANCET
- Statin-associated muscle symptoms—Managing the highly intolerant
- (2017) James M. Backes et al. Journal of Clinical Lipidology
- Consecución de objetivos terapéuticos de colesterol LDL en niños y adolescentes con hipercolesterolemia familiar. Registro longitudinal SAFEHEART
- (2017) Adriana Saltijeral et al. REVISTA ESPANOLA DE CARDIOLOGIA
- Association of Prior Authorization and Out-of-pocket Costs With Patient Access to PCSK9 Inhibitor Therapy
- (2017) Ann Marie Navar et al. JAMA Cardiology
- Drug treatment and adherence of subjects
- (2016) Manuela Casula et al. ATHEROSCLEROSIS
- Ezetimibe: Use, costs, and adverse events in Australia
- (2016) Samantha A. Hollingworth et al. Cardiovascular Therapeutics
- Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United StatesCLINICAL PERSPECTIVE
- (2016) Emil M. deGoma et al. Circulation-Cardiovascular Genetics
- Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia
- (2016) Leopoldo Perez de Isla et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statin Initiation During Childhood in Patients With Familial Hypercholesterolemia
- (2016) Marjet J.A.M. Braamskamp et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United StatesCLINICAL PERSPECTIVE
- (2016) Emil M. deGoma et al. Circulation-Cardiovascular Genetics
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- Long-Term Statin Treatment in Children with Familial Hypercholesterolemia: More Insight into Tolerability and Adherence
- (2015) Marjet J. A. M. Braamskamp et al. PEDIATRIC DRUGS
- Predicting non-adherence in patients with familial hypercholesterolemia
- (2014) J. M. H. Galema-Boers et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now